谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

ORIC-613, a Potential First- and Best-in-class, Orally Bioavailable, Potent and Selective PLK4 Inhibitor with Synthetic Lethality in TRIM37 High Cancer Models

Kyle A. Edgar,Siobhan McRee, Gina Andretta,Chelsea Chen,Christophe Colas, Wei Fang,Wayne Kong,Jason Long, Fang Liu,Jared Moore, Aleskandr Pankov, Dan Shore, Joanne Tan,Robert Warne,Livia Ulicna,Rakesh Vekariya,Anneleen Daemen, F. Romero,Melissa R. Junttila,Lori S. Friedman

Cancer Research（2024）

引用 0|浏览16
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要